nvista Holdings Corporation (NYSE: NVST) (“Envista”) will report financial results for its fourth quarter 2024 on Wednesday, February 5, 2025. Envista is moving the time of the conference call and will now discuss these results beginning at 2:30 PM PT on the same date. The call will last approximately one hour.
The call and the accompanying slide presentation will be webcast on the “Investors” section of Envista’s website, www.envistaco.com. A replay of the webcast will be available shortly after the conclusion of the presentation and will remain available for one year. You can access the conference call by dialing 800-225-9448 within the U.S. or +1 203-518-9708 outside the U.S. a few minutes before 2:30 PM PT and referencing conference ID #7185081.
Envista’s earnings press release, the webcast slides, and other related presentation materials will be posted to the “Investors” section of Envista’s website before the conference call and will remain available following the call.
About Envista Holdings Corporation
Envista is a global family of more than 30 trusted dental brands, including Nobel Biocare, Ormco, DEXIS, and Kerr, united by a shared purpose: to partner with professionals to improve lives. Envista helps its customers deliver the best possible patient care through industry-leading dental consumables, solutions, technology, and services.
Its comprehensive portfolio, including dental implants and treatment options, orthodontics, and digital imaging technologies, covers a wide range of dentists’ clinical needs for diagnosing, treating, and preventing dental conditions as well as improving the aesthetics of the human smile.
With a foundation comprised of the proven Envista Business System (EBS) methodology, an experienced leadership team, and a strong culture grounded in continuous improvement, commitment to innovation, and deep customer focus, Envista is well equipped to meet the end-to-end needs of dental professionals worldwide. Envista is one of the largest global dental products companies, with significant market positions in some of the most attractive segments of the dental products industry.
Source: www.envistaco.com
Products 27 March 2026
Garrison Dental Solutions has announced important enhancements to its Quad Matrix System with the release of updated Quad Wedges, building on the system’s strong clinical adoption for complex Class...
Products 20 February 2026
DEXIS™, a global leader in dental imaging, today introduced its most advanced update yet to the DTX Studio™ platform—bringing AI-driven diagnostics and multi-site connectivity designed to...
Periodontology 10 September 2025
To update the findings of a systematic review from the year 2016 on the evidence for the accuracy and potential benefits of cone beam computed tomography (CBCT) in periodontal diagnostics.
Oral carcinogenesis is a multifactorial process involving numerous genetic events that alter normal functions of oncogenes and tumour suppressor genes.
New surgical kits, a 6.0-mm implant, and upgraded accessories elevate the clinical ease and versatility of the company’s flagship system.
Endodontics 22 June 2026
This peer-reviewed endodontics article summarizes clinical evidence from Scientific reports (2026). It focuses on findings that may help dental professionals evaluate treatment decisions, patient...
News 22 June 2026
Nationally Recognized Cariology Leader to Help Advance Strategic Initiatives Focused on Disease Prevention, Value-Based Care, and Medical-Dental Integration
News 22 June 2026
After 3 days of presentations and collaboration amongst leadership teams, the organization honors trailblazers as the industry turns to the next 15 years.
Editorials 22 June 2026
Welcome to the inaugural Bits and Bites, a collection of some recent news items around Texas A&M College of Dentistry.